Montmed SiteSmart™ has provided an unrestricted grant to Pink Pearls Inc., a leading diabetes education and research consulting firm headed by key opinion leader Lori Berard, to assess SiteSmart™’s pen needle ability to clinically improve site rotation amongst insulin users. The Study aims at enrolling 240 patients across 20 retail pharmacies nationally, and to bring the clinical evidence behind SiteSmart™’s value proposition of being the only pen needles that improve site rotation amongst insulin users, for better outcomes. Results are expected to be released in the fourth quarter of 2019
